AMGN•benzinga•
FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients
Summary
FDA approves Amgen's Imdelltra for treating ES-SCLC, based on response rate and DoR in clinical studies. Approval may depend on further trials.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 17, 2024 by benzinga